$41M sweet spot round size
Most of their 53 investments are in rounds between $26M and $65M
1986
Cyteir Therapeutics raised $40M on October 15, 2019
Investors: Novo Holdings, Venrock, Lightstone Ventures, Osage University Partners (OUP) and Celgene
Anokion raised $40M on September 11, 2019
Investors: Celgene
Immatics Biotechnologies raised $75M on September 5, 2019
Investors: Celgene
Vividion Therapeutics. Inc. raised $82M on April 30, 2019
Investors: Nextech Invest, Cardinal Partners (CP), Casdin Capital, LLC, Mirae Asset MAPS Global Investments Co., Ltd, Versant Ventures, ARCH Venture Partners and Celgene
Arrakis Therapeutics raised $75M on April 18, 2019
Investors: Omega Funds, Nextech Invest, WuXi AppTec, GV, venBio Partners, Osage University Partners (OUP) and Celgene
HiberCell raised $61M on February 7, 2019
Investors: Life Sciences Fund Amsterdam, 6 Dimensions Capital, ARCH Venture Partners, Magnetic Ventures, Hillhouse Capital Management and Celgene
Biond Biologics Ltd raised $17M on January 8, 2019
Investors: Celgene
Exscientia raised $26M on January 7, 2019
Investors: Evotec and Celgene
Ribon Therapeutics raised $65M on January 4, 2019
Investors: The Column Group, Osage University Partners (OUP), Takeda UK Limited and Celgene
Undisclosed raised $120M on January 2, 2019
Investors: 泰福资本 TF Capital, Boyu Capital, Qiming Venture Partners, 泰康集团, FountainVest Partners and Celgene